Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1 361
1 285 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Abbvie Inc
ABBV
|
$219.68 |
-0.5%
|
$388.3B |
|
|
|
Astria Therapeutics Inc
ATXS
|
$5 784.3 |
+45 880.1%
|
$330.2B |
|
|
|
Amgen Inc
AMGN
|
$366.21 |
+0.5%
|
$197.2B |
|
|
|
Gilead Sciences Inc
GILD
|
$144.99 |
-1.6%
|
$179.9B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$469.34 |
+1.4%
|
$119.1B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$745.77 |
-2%
|
$78.8B |
|
|
|
argenx SE
ARGX
|
€609 |
0%
|
$44.4B |
|
|
|
CSL Ltd
CSL
|
AU$141.03 |
0%
|
$48.3B |
|
|
|
Alnylam Pharmaceuticals Inc
ALNY
|
$313.41 |
+0.6%
|
$41.4B |
1 280 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
